Abivax Sa ADR (ABVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 06-2024 | 12-2023 | 06-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -190,712 | -87,916 | -159,899 | -56,650 | -63,996 |
| Depreciation Amortization | 1,190 | 620 | 765 | 359 | 511 |
| Accounts receivable | N/A | 4,332 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -18,608 | N/A | N/A | N/A |
| Other Working Capital | 3,072 | -14,048 | 21,763 | 16,168 | -13,506 |
| Other Operating Activity | 19,729 | 23,894 | 32,247 | 10,029 | 20,164 |
| Operating Cash Flow | $-166,721 | $-91,725 | $-105,124 | $-30,094 | $-56,827 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -693 | -254 | -287 | -161 | -303 |
| Purchase Sale Intangibles | N/A | -3 | N/A | N/A | N/A |
| Other Investing Activity | 17,749 | 14,747 | -8,474 | -1,706 | -12,368 |
| Investing Cash Flow | $17,056 | $14,493 | $-8,761 | $-1,867 | $-12,671 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 52,277 | N/A | N/A | N/A |
| Debt Repayment | N/A | -4,711 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 263 | N/A | N/A | N/A |
| Other Financing Activity | 30,523 | -4,406 | 362,884 | 127,296 | 33,938 |
| Financing Cash Flow | $30,523 | $43,423 | $362,884 | $127,296 | $33,938 |
| Exchange Rate Effect | 2,578 | 1,906 | -5,489 | N/A | 0 |
| Beginning Cash Position | 272,626 | 271,316 | 29,168 | 29,386 | 63,955 |
| End Cash Position | 156,062 | 239,413 | 272,677 | 124,721 | 28,395 |
| Net Cash Flow | $-116,565 | $-31,903 | $243,509 | $95,336 | $-35,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | -166,721 | -91,725 | -105,124 | -30,094 | -56,827 |
| Capital Expenditure | N/A | -254 | N/A | N/A | N/A |
| Free Cash Flow | -166,721 | -91,979 | -105,124 | -30,094 | -56,827 |